Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker COYA
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 10, 2026 | COYA Coya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 14, 2026 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 5, 2026 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 15, 2026 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 11, 2026 | COYA Coya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 7, 2026 | COYA Coya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K/A | 8-K ↗ |
| Jun 25, 2026 | COYA Coya Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 12, 2026 | COYA Coya Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 12, 2026 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 12, 2026 | COYA Coya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 2, 2026 | COYA Coya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 16, 2026 | COYA Coya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 30, 2026 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 30, 2026 | COYA Coya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 30, 2026 | COYA Coya Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jan 30, 2026 | COYA Coya Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 20, 2026 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 8, 2026 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 17, 2025 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 12, 2025 | COYA Coya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2025 | COYA Coya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 27, 2025 | COYA Coya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 27, 2025 | COYA Coya Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 27, 2025 | COYA Coya Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Sep 2, 2025 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 12, 2025 | COYA Coya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2025 | COYA Coya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 29, 2025 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 1, 2025 | COYA Coya Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 26, 2025 | COYA Coya Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 13, 2025 | COYA Coya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 13, 2025 | COYA Coya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 18, 2025 | COYA Coya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 18, 2025 | COYA Coya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 6, 2024 | COYA Coya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 6, 2024 | COYA Coya Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 5, 2024 | COYA Coya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 31, 2024 | COYA Coya Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 29, 2024 | COYA Coya Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
39 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:15 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances